Cara Therapeutics (CARA) – FDA
-
Cara Therapeutics (CARA) Announces Outcome from Dose-Finding Part A of KIND 1 Study of Oral Difelikefalin
-
Cara Therapeutics (CARA) Announces Approval of KORSUVA IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CARA Stock Lookup